Uganda sits astride the equator in a highland zone where elevation modulates tropical disease patterns. Kampala rests at 1,190 meters, Kabale in the southwest reaches 1,950 meters, while the Albertine Rift valleys and Lake Victoria shorelines drop below 1,000 meters. These altitude differences determine malaria transmission intensity, which remains the primary health consideration for all travelers regardless of itinerary. Yellow fever vaccination is mandatory for entry and enforced at Entebbe International Airport. The certificate must show vaccination at least ten days before arrival. Uganda places this requirement on all arriving international passengers over one year of age, with limited exceptions for infants and medical contraindications documented by a physician.
Malaria transmission occurs throughout Uganda year-round below 2,000 meters elevation. This includes Kampala, Entebbe, Jinja, all national parks except the highest slopes of Mount Elgon and Rwenzori Mountains, and the entire Lake Victoria basin. The primary vector is Anopheles gambiae. Plasmodium falciparum causes approximately ninety-five percent of infections, a strain that can progress rapidly without treatment. The Ministry of Health surveillance data from 2019 showed malaria accounted for thirty to fifty percent of outpatient visits at health facilities nationally. For travelers, this translates to prophylaxis necessity rather than option. Atovaquone-proguanil, doxycycline, and mefloquine remain the standard prophylactic medications, with primaquine used in specific terminal prophylaxis protocols. Chloroquine resistance renders that drug ineffective in Uganda. Prophylaxis must begin before entering malaria zones—timing varies by medication from one day to two weeks—and continue after departure for durations ranging from one week to four weeks depending on the agent selected. A physician specializing in travel medicine should prescribe based on individual medical history, planned itinerary, and duration of stay.
Typhoid fever maintains endemic presence in Uganda, transmitted through contaminated water and food. The injectable Vi polysaccharide vaccine provides protection for two years, while the oral Ty21a vaccine requires four capsules taken on alternate days and protects for five years. Neither vaccine achieves one hundred percent efficacy, making water and food precautions essential regardless of vaccination status. Hepatitis A spreads through the same fecal-oral route as typhoid. Two doses of hepatitis A vaccine spaced six to twelve months apart provide protection lasting at least twenty years. The first dose alone gives adequate coverage for trips under one year. These two vaccines—typhoid and hepatitis A—rank immediately after yellow fever and malaria prophylaxis in the preparation sequence for Uganda.
Routine vaccinations require verification before departure. Measles outbreaks occurred in Uganda in 2017, 2019, and 2022, primarily affecting unvaccinated children but occasionally reaching adults without immunity. The MMR vaccine series should be confirmed complete per home country schedules. Polio remains eliminated from Uganda since the last wild case in 1996, but the country participates in regional surveillance due to circulation in neighboring Democratic Republic of Congo. A single adult booster of inactivated polio vaccine suffices for travelers who completed childhood series. Tetanus-diphtheria boosters maintain effectiveness for ten years. COVID-19 vaccination requirements changed throughout 2021-2023, with Uganda removing entry mandates in 2023, though this status remains subject to change and requires verification at time of travel planning.
Hepatitis B vaccination merits consideration based on planned activities. Transmission occurs through blood exposure, sexual contact, and contaminated medical equipment. Healthcare workers, long-term residents exceeding six months, and anyone anticipating medical procedures in Uganda should complete the three-dose series ideally starting six months before departure, though accelerated schedules exist. Rabies pre-exposure prophylaxis requires three doses over three to four weeks. Uganda hosts rabies in dogs, bats, and occasionally monkeys. The vaccine does not eliminate need for post-exposure treatment but reduces the number of injections required and extends the window for seeking care. Rabies immune globulin, the critical component of post-exposure treatment for unvaccinated individuals, maintains limited availability outside Kampala. Travelers planning extended time in rural areas, working with animals, or visiting Kibale National Park, Queen Elizabeth National Park, or other locations with bat caves should discuss pre-exposure vaccination with a physician. Bwindi Impenetrable National Park gorilla tracking does not create significant rabies exposure risk, as mountain gorillas do not carry the virus and contact remains prohibited.
Meningococcal meningitis occurs in Uganda as part of the African meningitis belt, though the country sits at the belt's southern periphery with lower incidence than Sahel nations. The quadrivalent ACWY conjugate vaccine provides protection for five years and receives recommendation for travelers during December through June dry season, particularly those visiting northern districts including Gulu, Lira, and Arua. Outbreaks in Uganda have occurred episodically, most recently documented in 2017 in West Nile region. Cholera outbreaks emerge sporadically, tied to water source contamination during floods or in refugee settlement areas. The oral cholera vaccine provides moderate protection for two years but remains optional for conventional tourists, becoming more relevant for aid workers or those working in water-stressed communities.
Tuberculosis prevalence in Uganda measured 200 cases per 100,000 population in 2021 according to World Health Organization data. The BCG vaccine given in many countries during childhood provides inconsistent protection in adults and is not recommended as a pre-travel intervention. Risk to short-term travelers remains low. Long-term residents or healthcare workers should arrange baseline tuberculin skin testing or interferon-gamma release assay before departure and repeat testing after return, following occupational health protocols rather than travel medicine frameworks.
Schistosomiasis infects an estimated four million Ugandans, transmitted through freshwater contact with larvae shed by specific snail species. Lake Victoria shorelines, Lake Albert, Lake Edward, and slow-moving sections of rivers harbor the parasites. Schistosoma mansoni affects intestines and liver, while S. haematobium targets the urinary tract. No vaccine exists. Swimming, wading, or any freshwater contact in these bodies creates infection risk. The parasites penetrate intact skin within minutes. Chlorinated swimming pools and rapid-moving river sections above waterfalls present negligible risk. Travelers planning water activities on Lake Victoria or other lakes should consult a physician regarding presumptive treatment with praziquantel six to eight weeks after last exposure, when adult parasites become susceptible to medication but before chronic infection establishes. Marine water in Uganda does not exist, as the country remains landlocked.
African trypanosomiasis, known as sleeping sickness, persists in Uganda at low endemic levels. The tsetse fly Glossina fuscipes transmits Trypanosoma brucei rhodesiense in game parks including Murchison Falls National Park, Queen Elizabeth National Park, and Lake Mburo National Park. Reported cases number fewer than one hundred annually nationwide according to Ministry of Health surveillance, with tourist infections exceedingly rare but documented. Tsetse flies are large, brown, and bite during daylight hours through light fabric. No vaccine or prophylactic medication exists. Repellents with DEET concentration of thirty percent or higher provide moderate protection, though tsetse flies are less deterred by repellents than mosquitoes. Wearing neutral colors—khaki, beige, grey—reduces attraction, as tsetse flies orient toward dark blue and black. Symptoms begin one to three weeks after bite with fever, headache, and painful skin lesion at bite site, progressing to neurological involvement if untreated. Any fever developing during or after visiting game parks requires immediate medical evaluation.
Chikungunya and dengue fever transmission occurs in Uganda through Aedes aegypti mosquitoes, which bite during daytime. Outbreaks have been documented in Kampala and surrounding central region. Neither disease has a vaccine available to travelers as of 2024. The dengue vaccine Dengvaxia carries restrictions and is not recommended for dengue-naive individuals. Prevention relies entirely on avoiding mosquito bites through DEET repellent, permethrin-treated clothing, and long sleeves during dawn and dusk activity periods. Zika virus circulates at low levels in Uganda, with documented cases but no major outbreaks. Pregnant women and those planning pregnancy within three months should consult physicians regarding travel to Uganda given Zika's association with birth defects.